277 related articles for article (PubMed ID: 29272439)
1. Characterization of OXA-48-like carbapenemase producers in Canada, 2011-14.
Mataseje LF; Boyd DA; Fuller J; Haldane D; Hoang L; Lefebvre B; Melano RG; Poutanen S; Van Caeseele P; Mulvey MR
J Antimicrob Chemother; 2018 Mar; 73(3):626-633. PubMed ID: 29272439
[TBL] [Abstract][Full Text] [Related]
2. OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014.
Findlay J; Hopkins KL; Loy R; Doumith M; Meunier D; Hill R; Pike R; Mustafa N; Livermore DM; Woodford N
J Antimicrob Chemother; 2017 May; 72(5):1340-1349. PubMed ID: 28199647
[TBL] [Abstract][Full Text] [Related]
3. Enterobacteriaceae producing OXA-48-like carbapenemases in Poland, 2013-January 2017.
Izdebski R; Baraniak A; Zabicka D; Machulska M; Urbanowicz P; Fiett J; Literacka E; Bojarska K; Kozinska A; Zieniuk B; Hryniewicz W; Gniadkowski M;
J Antimicrob Chemother; 2018 Mar; 73(3):620-625. PubMed ID: 29237086
[TBL] [Abstract][Full Text] [Related]
4. Early OXA-48-Producing
Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
[TBL] [Abstract][Full Text] [Related]
5. Molecular Characterization of OXA-48-Like-Producing Enterobacteriaceae in the Czech Republic and Evidence for Horizontal Transfer of pOXA-48-Like Plasmids.
Skalova A; Chudejova K; Rotova V; Medvecky M; Studentova V; Chudackova E; Lavicka P; Bergerova T; Jakubu V; Zemlickova H; Papagiannitsis CC; Hrabak J
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855076
[TBL] [Abstract][Full Text] [Related]
6. Epidemic spread of OXA-48 beta-lactamase in Croatia.
Bedenić B; Slade M; Starčević LŽ; Sardelić S; Vranić-Ladavac M; Benčić A; Zujić Atalić V; Bogdan M; Bubonja-Šonje M; Tomić-Paradžik M; Tot T; Lukić-Grlić A; Drenjančević D; Varda-Brkić D; Bandić-Pavlović D; Mihaljević S; Zarfel G; Gužvinec M; Conzemius R; Barišić I; Tambić-Andraševic A
J Med Microbiol; 2018 Aug; 67(8):1031-1041. PubMed ID: 29927373
[TBL] [Abstract][Full Text] [Related]
7. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11).
Österblad M; Kirveskari J; Hakanen AJ; Tissari P; Vaara M; Jalava J
J Antimicrob Chemother; 2012 Dec; 67(12):2860-4. PubMed ID: 22855858
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
[TBL] [Abstract][Full Text] [Related]
9. Carbapenemase and virulence factors of Enterobacteriaceae in North Lebanon between 2008 and 2012: evolution via endemic spread of OXA-48.
Beyrouthy R; Robin F; Dabboussi F; Mallat H; Hamzé M; Bonnet R
J Antimicrob Chemother; 2014 Oct; 69(10):2699-705. PubMed ID: 24903637
[TBL] [Abstract][Full Text] [Related]
10. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.
Jayol A; Poirel L; Dortet L; Nordmann P
Euro Surveill; 2016 Sep; 21(37):. PubMed ID: 27685838
[TBL] [Abstract][Full Text] [Related]
11. Fecal Carriage and Molecular Characterization of Carbapenemase-Producing
Pérez-López A; Sundararaju S; Tsui KM; Al-Mana H; Hasan MR; Suleiman M; Al Maslamani E; Imam O; Roscoe D; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0112221. PubMed ID: 34756089
[TBL] [Abstract][Full Text] [Related]
12. Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014.
Dortet L; Cuzon G; Ponties V; Nordmann P
Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205502
[TBL] [Abstract][Full Text] [Related]
13. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
14. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
Oteo J; Ortega A; Bartolomé R; Bou G; Conejo C; Fernández-Martínez M; González-López JJ; Martínez-García L; Martínez-Martínez L; Merino M; Miró E; Mora M; Navarro F; Oliver A; Pascual Á; Rodríguez-Baño J; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Pérez-Vázquez M; Campos J;
Antimicrob Agents Chemother; 2015; 59(6):3406-12. PubMed ID: 25824224
[TBL] [Abstract][Full Text] [Related]
15. Detection of VIM, NDM and OXA-48 producing carbapenem resistant Enterobacterales among clinical isolates in Southern Hungary.
Gajdács M; Ábrók M; Lázár A; Jánvári L; Tóth Á; Terhes G; Burián K
Acta Microbiol Immunol Hung; 2020 Dec; 67(4):209-215. PubMed ID: 33258795
[TBL] [Abstract][Full Text] [Related]
16. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.
Samuelsen Ø; Overballe-Petersen S; Bjørnholt JV; Brisse S; Doumith M; Woodford N; Hopkins KL; Aasnæs B; Haldorsen B; Sundsfjord A;
PLoS One; 2017; 12(11):e0187832. PubMed ID: 29141051
[TBL] [Abstract][Full Text] [Related]
17. Characterization of carbapenemase-producing Enterobacteriaceae in the West Midlands region of England: 2007-14.
Findlay J; Hopkins KL; Alvarez-Buylla A; Meunier D; Mustafa N; Hill R; Pike R; McCrae LX; Hawkey PM; Woodford N
J Antimicrob Chemother; 2017 Apr; 72(4):1054-1062. PubMed ID: 28073969
[TBL] [Abstract][Full Text] [Related]
18. Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study).
Hernández-García M; García-Fernández S; García-Castillo M; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Costa E; Ramalheira E; Sancho L; Diogo J; Ferreira R; Silva T; Chaves C; Pássaro L; Paixão L; Romano J; Cantón R;
Int J Antimicrob Agents; 2021 Feb; 57(2):106259. PubMed ID: 33310115
[TBL] [Abstract][Full Text] [Related]
19. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
Moubareck CA; Mouftah SF; Pál T; Ghazawi A; Halat DH; Nabi A; AlSharhan MA; AlDeesi ZO; Peters CC; Celiloglu H; Sannegowda M; Sarkis DK; Sonnevend Á
Int J Antimicrob Agents; 2018 Jul; 52(1):90-95. PubMed ID: 29530587
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK.
Dimou V; Dhanji H; Pike R; Livermore DM; Woodford N
J Antimicrob Chemother; 2012 Jul; 67(7):1660-5. PubMed ID: 22532467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
